Haemophilus b conjugate (prp-omp) vaccine Pregnancy and Breastfeeding Warnings
Brand names: Liquid PedvaxHIB
Medically reviewed by Drugs.com. Last updated on Dec 4, 2023.
Haemophilus b conjugate (prp-omp) vaccine Pregnancy Warnings
Animal studies are not available. There are no controlled data in human pregnancy.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Safety has not been established. This vaccine is only approved for use in young children.
US FDA pregnancy category: C
Haemophilus b conjugate (prp-omp) vaccine Breastfeeding Warnings
This vaccine is only approved for use in young children.
Excreted into human milk: Data not available
Excreted into animal milk: Data not available
See also
References for pregnancy information
- Product Information. Liquid PedvaxHIB (haemophilus b conjugate (PRP-OMP) vaccine). Merck & Co., Inc. 2022.
References for breastfeeding information
- Product Information. Liquid PedvaxHIB (haemophilus b conjugate (PRP-OMP) vaccine). Merck & Co., Inc. 2022.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
